Cash & equivalents decreased 69.6%
Cash & equivalents changed -69.6% from the comparable as-filed period.
$2.4M→$741,3243 prior comparisons
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -69.6% from the comparable as-filed period.
Current assets changed -60.7% from the comparable as-filed period.
Current liabilities changed -30.5% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.